Indication
APOL1-mediated Kidney Disease
1 clinical trial
2 products
Clinical trial
A Phase I, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of VX-840 in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-11-07
Product
PlaceboProduct
VX-840